Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

KAA-276, a novel long-acting histamine H1 antagonist for inhalation administration

May 11, 1998

New substituted aromatic compounds for asthma, joint inflammation

May 11, 1998

Comparative studies of L-0066 in animal models of allergic bronchial inflammation

May 11, 1998

Phase III trials with SB-207499 begin

May 8, 1998

Levalbuterol shows improved therapeutic ratio over racemic albuterol

May 8, 1998

P&U reports antiasthma agent with a novel mechanism of action

May 8, 1998

Profile of BIIC-1996, a novel dual NK1/NK2 antagonist for respiratory indications

May 8, 1998

Manganic porphyrins for treatment of hyperoxic lung injury

May 8, 1998

CNRS investigators discover CFTR channel activators

May 8, 1998

Antiallergic/antiinflammatory effects of heparin and heparin fractions under evaluation

May 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...